Loading ...

Abrocitinib Plus Peanut OIT Examining Combination Therapy

(

APEX

)

ITN Protocol #:

ITN099AD

Branded Name:

APEX

ClinicalTrials.Gov ID:

Treatment Protocol #:

Therapeutic Area:

Allergy & Asthma

Current Status:

Withdrawn

Summary:

Efficacy of Abrocitinib in Peanut Oral Immunotherapy: A Randomized Double Blind Placebo Controlled Trial

Clinical Operations Manager

ITN Biologist

ITN Clinical Trial Physician

NIAID Project Manager

NIAID Regulator Officer

Rho Scientist

Study Personnel:

Protocol Chair

Scott Sicherer, MDscott.sicherer@mssm.edu

Work: 

212-241-5548

Protocol Chair

Nicole Ramsey

Work: 

Protocol Chair

Emerson Sosaesosa@immunetolerance.org

Work: 

415-218-7981

Protocol Chair

Carolyn Baloh, MDcbaloh@immunetolerance.org

Work: 

412-508-5216

Protocol Chair

Tatyana Vaysmantatyana.vaysman@nih.gov

Work: 

301-761-7739

Protocol Chair

Paul Price, PhDpaul.price@nih.gov

Work: 

301-761-7835

Protocol Chair

Lars Dunaway, PhDLars_Dunaway@rhoworld.com

Work: 

(919) 595-6382